Showing results for "#Memorial Sloan Kettering Cancer Center"

Study finds breast cancer drug with a serious side effect

In 2019, the US Food and Drug Administration (FDA) approved the use of this drug in combination with fulvestrant, an oestrogen receptor blocker, for...